The largest database of trusted experimental protocols

Plat e cells

Manufactured by Promega
Sourced in United States

Plat-E cells are a laboratory-generated cell line designed for efficient retroviral vector production. They provide a stable platform for the high-titer production of retroviral particles, which can be used for a variety of applications, such as gene delivery and gene expression studies.

Automatically generated - may contain errors

4 protocols using plat e cells

1

Lentiviral Transduction and Clonal Expansion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plat-E cells (Cell Biolabs) were maintained in complete media supplemented with 1 μg/ml puromycin and 10 μg/ml blasticidin and plated at ∼80% confluency the day before transfection. Plat-E cells were transfected with FuGENE HD (Promega) and transfection regent was incubated overnight before a media change. Viral supernatants were collected at ∼48, 56, 72, and 80 h post-transfection and incubated with MEFs in the presence of 8 mg/ml polybrene. ∼16 h after the last viral transduction, MEF cells were split and selection medium was added if needed (1 μg/ml puromycin or 200 μg/ml hygromycin).
Clonal populations were generated by plating cells at very low density and clones were collected onto sterile filter paper dots soaked in trypsin. After expansion, whole-cell extracts from clonal populations were screened by Western blot analysis for mitofusin against wild-type controls.
+ Open protocol
+ Expand
2

Retrovirus-mediated Hras V12 Transformation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plat-E cells (Cell Biolabs, San Diego, CA, USA) were used to produce retrovirus according to the manufacturer's instructions. Plat-E cells were transfected with pBABE-puro and pBABE-puro Hras V12 (a generous gift from Martine F. Roussel/Scott Lowe) by using FuGENE 6 (Promega, Fitchburg, WI, USA). Retroviral supernatant was filtered and mixed with 4 μg/ml polybrene (EMD Millipore). MEF cells were infected with retroviral supernatant twice and selected in the presence of 2 μg/ml of puromycin (Sigma-Aldrich, St. Louis, MO, USA) for 4 days.
Focus-formation assays were performed as previously described.35 (link) Briefly, 103 MEF cells infected with retrovirus were mixed with 3 × 105 uninfected MEF cells, and the mixture was cultured in a 100-mm dish in triplicate. Medium was changed every 2 or 3 days. After 2 weeks incubation, foci were stained with giemsa stain (Sigma-Aldrich), and the number of foci was counted.
+ Open protocol
+ Expand
3

Generating Mitofusin-expressing Clonal MEFs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plat-E cells (Cell Biolabs) were maintained in complete media supplemented with 1 μg/ml puromycin and 10 μg/ml blasticidin and plated at ∼80% confluency the day before transfection. Plat-E cells were transfected with FuGENE HD (Promega) and transfection regent was incubated overnight before a media change. Viral supernatants were collected at ∼48, 56, 72, and 80 h posttransfection and incubated with MEFs in the presence of 8 mg/ml polybrene. Approximately 16 h after the last viral transduction, MEF cells were split and selection was added if needed (1 μg/ml puromycin or 200 μg/ml hygromycin).
Clonal populations were generated by plating cells at very low density and clones were collected onto sterile filter paper dots soaked in trypsin. Following expansion, whole cell extract from clonal populations was screened by Western blot analysis for mitofusin against wild-type controls.
+ Open protocol
+ Expand
4

Overexpression of Mitofusin Proteins in MEFs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plat-E cells (Cell Biolabs) were maintained in complete media supplemented with 1 μg/ml puromycin and 10 μg/ml blasticidin and plated at ∼80% confluency the day before transfection. 350,000 Plat-E cells were plated in a six-well dish and the following day were transfected with pBABE plasmids (3 μg pBABE Mfn1 or an empty vector; 1.5–3 μg pBABE Mfn2; 3 μg mito-paGFP) using FuGENE HD (Promega) and Opti-MEM reduced serum media (Gibco). Transfection reagent was incubated overnight before a media change. Viral supernatants were collected at ∼48 and 72 h post-transfection and incubated with MEFs in the presence of 8 μg/ml polybrene. ∼24 h after the last viral transduction, MEF cells were split and selection was added (1 μg/ml puromycin or 200 μg/ml hygromycin B).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!